Baclofen Dosing for Adults with Normal Renal and Hepatic Function
For adults with normal renal and hepatic function, start baclofen at 5 mg three times daily and increase by 5 mg per dose every 3 days until optimal effect is achieved, typically between 40-80 mg daily, with a maximum of 80 mg daily (20 mg four times daily). 1
Starting Dose and Titration Schedule
The FDA-approved dosing regimen follows a structured titration protocol 1:
- Days 1-3: 5 mg three times daily (15 mg/day total)
- Days 4-6: 10 mg three times daily (30 mg/day total)
- Days 7-9: 15 mg three times daily (45 mg/day total)
- Days 10-12: 20 mg three times daily (60 mg/day total)
- Beyond Day 12: Further increases may be necessary, but do not exceed 80 mg/day (20 mg four times daily)
This gradual titration approach minimizes dose-dependent adverse effects such as sedation, dizziness, and somnolence, which are particularly problematic in clinical practice 2.
Optimal Therapeutic Dose
The lowest dose compatible with optimal response should be used 1. Most patients achieve adequate spasticity control between 40-80 mg daily 1. Recent systematic review evidence suggests that doses up to 50-60 mg/day provide the best balance of efficacy (increased abstinent days, reduced craving in alcohol use disorder studies) versus tolerability, with higher doses associated with increased dropout rates due to adverse events 3.
Important Clinical Considerations
Renal function monitoring is critical because baclofen is primarily renally cleared 1, 4. Even in patients with "normal" baseline function, pharmacokinetic studies demonstrate that baclofen clearance correlates directly with creatinine clearance 4. Time-to-peak plasma levels and half-lives may be substantially longer than initially reported, particularly with chronic dosing 5.
Common adverse events include fatigue, dizziness, somnolence/sedation, dry mouth, paresthesia, and muscle spasms 6. These are dose-dependent and typically mild to moderate in severity.
Discontinuation Protocol
Never abruptly discontinue baclofen 1. If benefits are not evident after a reasonable trial period, patients must be slowly withdrawn to avoid potentially life-threatening withdrawal syndrome, which can include hallucinations, seizures, and autonomic instability 7.
Context-Specific Dosing
For spasticity management (the FDA-approved indication), the standard 40-80 mg/day range is appropriate 8, 1. Oral baclofen may cause significant sedation and has less impact on spasticity in stroke victims compared to other conditions 8.
For muscle cramps in cirrhosis, start at 10 mg/day with weekly increases of 10 mg/day up to 30 mg/day 9.
High-dose baclofen (>80 mg/day up to 300 mg/day) has been studied off-label for alcohol use disorder, but evidence shows no additional benefit and increased adverse events 10, 6, 3. Such dosing exceeds FDA recommendations and should only be considered by specialists in specific clinical contexts.